MktsMarkets

Allarity Therapeutics, Inc.
NASDAQ: ALLRKey statistics
ALLR News
Stories mentioning ALLR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,297 | 1,674 | 1,203 | 2,321 | 1,403 | 1,847 | 1,021 | 1,058 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,713 | 3,238 | 2,518 | 4,133 | 3,036 | 7,317 | 12,313 | 3,371 |
| Operating Income (Loss) | (2,688) | (2,918) | (2,518) | (4,133) | (3,036) | (7,317) | (12,313) | (3,371) |
| Interest Income | 163.00 | 155.00 | 187.00 | 237.00 | 222.00 | 219.00 | 261.00 | 53.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (3,373) | (2,806) | (2,320) | (2,732) | (7,453) | (11,967) | (1,629) | |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (377.00) | 0.00 | |
| Net Income (Loss) | (2,750) | (3,373) | (2,806) | (2,320) | (2,732) | (7,453) | (11,590) | (1,629) |
| Earnings Per Share (Basic) | (0.17) | (0.23) | (0.19) | (0.15) | (0.25) | (4.64) | (7.71) | (3.34) |
| Earnings Per Share (Diluted) | (0.11) | |||||||
| Weighted Average Shares Outstanding (Basic) | 15,969 | 14,379 | 14,740 | 15,543 | 11,147 | 1,607 | 1,576 | 499.00 |
| Weighted Average Shares Outstanding (Diluted) | 14,979 | |||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ALLR
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a stock listed on the Nasdaq Stock Market under the ticker symbol ALLR. It last traded at $0.9800 (Nov 2, 2026, 4:00 PM ET), up 12.3% on the day. That gives Allarity Therapeutics a market capitalisation of $15.6M.
Over the past 52 weeks ALLR has traded between $0.7700 and $1.84.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.8M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.8M |
| Dec 31, 2025 | — | -$3.4M |
| Sep 30, 2025 | — | -$2.8M |
| Jun 30, 2025 | — | -$2.3M |
From Allarity Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…